WAVE LIFE SCIENCES LTD. Operating Expenses
WAVE LIFE SCIENCES LTD. (WVE) reported Operating Expenses of $76.07 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-07-30
- WAVE LIFE SCIENCES LTD. operating expenses for the quarter ending 2026-06-30 was $76.07M, a 23.78% increase year-over-year.
- WAVE LIFE SCIENCES LTD. operating expenses for the quarter ending 2026-03-31 was $69.54M, a 17.91% increase year-over-year.
- WAVE LIFE SCIENCES LTD. operating expenses for the quarter ending 2025-12-31 was $73.71M, a 21.27% increase year-over-year.
- WAVE LIFE SCIENCES LTD. operating expenses for the quarter ending 2025-09-30 was $63.96M, a 13.73% increase year-over-year.
- WAVE LIFE SCIENCES LTD. operating expenses for fiscal 2025 was $258.11M, a 18.02% increase from fiscal 2024.
- WAVE LIFE SCIENCES LTD. operating expenses for fiscal 2024 was $218.71M, a 20.63% increase from fiscal 2023.
- WAVE LIFE SCIENCES LTD. operating expenses for fiscal 2023 was $181.30M, a 8.98% increase from fiscal 2022.
- WAVE LIFE SCIENCES LTD. operating expenses for fiscal 2022 was $166.37M, a 0.96% decline from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $76.07M 10-Q · filed 2026-07-30 | $145.62M 10-Q · filed 2026-07-30 | $219.33M derived: sum of 3 quarters · filed 2026-07-30 | $283.29M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $69.54M 10-Q · filed 2026-04-28 | $143.26M derived: sum of 2 quarters · filed 2026-04-28 | $207.22M derived: sum of 3 quarters · filed 2026-04-28 | $268.68M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $73.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $137.67M derived: sum of 2 quarters · filed 2026-02-26 | $199.13M derived: sum of 3 quarters · filed 2026-07-30 | $258.11M 10-K · filed 2026-02-26 |
| 2025-09-30 | $63.96M 10-Q · filed 2025-11-10 | $125.42M derived: sum of 2 quarters · filed 2026-07-30 | $184.40M 10-Q · filed 2025-11-10 | $245.18M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $61.46M 10-Q · filed 2026-07-30 | $120.44M 10-Q · filed 2026-07-30 | $181.22M derived: sum of 3 quarters · filed 2026-07-30 | $237.46M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $58.98M 10-Q · filed 2026-04-28 | $119.76M derived: sum of 2 quarters · filed 2026-04-28 | $176.00M derived: sum of 3 quarters · filed 2026-04-28 | $230.69M derived: sum of 4 quarters · filed 2026-04-28 |
| 2024-12-31 | $60.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $117.02M derived: sum of 2 quarters · filed 2026-02-26 | $171.71M derived: sum of 3 quarters · filed 2026-02-26 | $218.71M 10-K · filed 2026-02-26 |
| 2024-09-30 | $56.24M 10-Q · filed 2025-11-10 | $110.93M derived: sum of 2 quarters · filed 2025-11-10 | $157.92M 10-Q · filed 2025-11-10 | $205.66M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $54.69M 10-Q · filed 2025-07-30 | $101.69M 10-Q · filed 2025-07-30 | $149.42M derived: sum of 3 quarters · filed 2026-02-26 | $194.19M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $47.00M 10-Q · filed 2025-05-08 | $94.73M derived: sum of 2 quarters · filed 2026-02-26 | $139.50M derived: sum of 3 quarters · filed 2026-02-26 | $185.08M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $47.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $92.51M derived: sum of 2 quarters · filed 2026-02-26 | $138.09M derived: sum of 3 quarters · filed 2026-02-26 | $181.30M 10-K · filed 2026-02-26 |
| 2023-09-30 | $44.77M 10-Q · filed 2024-11-12 | $90.35M derived: sum of 2 quarters · filed 2024-11-12 | $133.56M 10-Q · filed 2024-11-12 | $178.37M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-06-30 | $45.58M 10-Q · filed 2024-08-08 | $88.79M 10-Q · filed 2024-08-08 | $133.59M derived: sum of 3 quarters · filed 2025-03-04 | $172.78M derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-03-31 | $43.21M 10-Q · filed 2024-05-10 | $88.02M derived: sum of 2 quarters · filed 2025-03-04 | $127.20M derived: sum of 3 quarters · filed 2025-03-04 | $169.74M derived: sum of 4 quarters · filed 2025-03-04 |
| 2022-12-31 | $44.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $83.99M derived: sum of 2 quarters · filed 2025-03-04 | $126.53M derived: sum of 3 quarters · filed 2025-03-04 | $166.37M 10-K · filed 2025-03-04 |
| 2022-09-30 | $39.18M 10-Q · filed 2023-11-09 | $81.72M derived: sum of 2 quarters · filed 2023-11-09 | $121.57M 10-Q · filed 2023-11-09 | $159.44M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $42.54M 10-Q · filed 2023-08-03 | $82.38M 10-Q · filed 2023-08-03 | $120.26M derived: sum of 3 quarters · filed 2023-08-03 | $164.29M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $39.84M 10-Q · filed 2023-05-03 | $77.72M derived: sum of 2 quarters · filed 2023-05-03 | $121.75M derived: sum of 3 quarters · filed 2023-05-03 | $164.35M derived: sum of 4 quarters · filed 2023-05-03 |
| 2021-12-31 | $37.88M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $81.91M derived: sum of 2 quarters · filed 2023-03-23 | $124.51M derived: sum of 3 quarters · filed 2023-03-23 | $167.98M 10-K · filed 2023-03-23 |
| 2021-09-30 | $44.03M 10-Q · filed 2022-11-10 | $86.63M derived: sum of 2 quarters · filed 2022-11-10 | $130.10M 10-Q · filed 2022-11-10 | $169.86M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $42.60M 10-Q · filed 2022-08-11 | $86.08M 10-Q · filed 2022-08-11 | $125.83M derived: sum of 3 quarters · filed 2022-08-11 | $163.69M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $43.47M 10-Q · filed 2022-05-12 | $83.22M derived: sum of 2 quarters · filed 2022-05-12 | $121.09M derived: sum of 3 quarters · filed 2022-05-12 | $162.77M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $39.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $77.62M derived: sum of 2 quarters · filed 2022-03-03 | $119.30M derived: sum of 3 quarters · filed 2022-03-03 | $173.45M 10-K · filed 2022-03-03 |
| 2020-09-30 | $37.87M 10-Q · filed 2021-11-10 | $79.55M derived: sum of 2 quarters · filed 2021-11-10 | $133.70M 10-Q · filed 2021-11-10 | $196.63M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $41.68M 10-Q · filed 2021-08-05 | $95.84M 10-Q · filed 2021-08-05 | $158.77M derived: sum of 3 quarters · filed 2021-08-05 | $215.88M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $54.15M 10-Q · filed 2021-05-13 | $117.09M derived: sum of 2 quarters · filed 2021-05-13 | $174.19M derived: sum of 3 quarters · filed 2021-05-13 | $227.44M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $62.93M 10-K · filed 2020-03-02 | $120.04M derived: sum of 2 quarters · filed 2020-11-09 | $173.29M derived: sum of 3 quarters · filed 2020-11-09 | $224.30M 10-K · filed 2021-03-04 |
| 2019-09-30 | $57.11M 10-Q · filed 2020-11-09 | $110.35M derived: sum of 2 quarters · filed 2020-11-09 | $161.37M 10-Q · filed 2020-11-09 | $213.93M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $53.24M 10-Q · filed 2020-08-10 | $104.26M 10-Q · filed 2020-08-10 | $156.82M derived: sum of 3 quarters · filed 2020-08-10 | $199.55M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $51.01M 10-Q · filed 2020-05-11 | $103.58M derived: sum of 2 quarters · filed 2020-05-11 | $146.30M derived: sum of 3 quarters · filed 2020-05-11 | $187.75M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $52.56M 10-K · filed 2020-03-02 | $95.29M derived: sum of 2 quarters · filed 2020-03-02 | $136.74M derived: sum of 3 quarters · filed 2020-03-02 | $173.94M 10-K · filed 2020-03-02 |
| 2018-09-30 | $42.73M 10-K · filed 2020-03-02 | $84.18M derived: sum of 2 quarters · filed 2020-03-02 | $121.37M 10-Q · filed 2019-11-05 | $153.63M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $41.45M 10-K · filed 2020-03-02 | $78.65M 10-Q · filed 2019-08-06 | $110.91M derived: sum of 3 quarters · filed 2020-03-02 | $138.57M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $37.20M 10-K · filed 2020-03-02 | $69.45M derived: sum of 2 quarters · filed 2020-03-02 | $97.12M derived: sum of 3 quarters · filed 2020-03-02 | $122.89M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $32.26M 10-K · filed 2019-03-01 | $59.92M derived: sum of 2 quarters · filed 2019-03-01 | $85.69M derived: sum of 3 quarters · filed 2019-03-01 | $106.28M 10-K · filed 2020-03-02 |
| 2017-09-30 | $27.67M 10-K · filed 2019-03-01 | $53.44M derived: sum of 2 quarters · filed 2019-03-01 | $74.03M 10-Q · filed 2018-11-09 | $93.21M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $25.77M 10-K · filed 2019-03-01 | $46.36M 10-Q · filed 2018-08-09 | $65.54M derived: sum of 3 quarters · filed 2019-03-01 | $83.17M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $20.59M 10-K · filed 2019-03-01 | $39.77M derived: sum of 2 quarters · filed 2019-03-01 | $57.40M derived: sum of 3 quarters · filed 2019-03-01 | $69.45M derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $19.18M 10-K · filed 2018-03-12 | $36.80M derived: sum of 2 quarters · filed 2018-03-12 | $48.86M derived: sum of 3 quarters · filed 2018-03-12 | $56.81M 10-K · filed 2019-03-01 |
| 2016-09-30 | $17.63M 10-K · filed 2018-03-12 | $29.68M derived: sum of 2 quarters · filed 2018-03-12 | $37.63M 10-Q · filed 2017-11-09 | $44.85M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $12.05M 10-K · filed 2018-03-12 | $20.01M 10-Q · filed 2017-08-09 | $27.22M derived: sum of 3 quarters · filed 2018-03-12 | $32.21M derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $7.95M 10-K · filed 2018-03-12 | $15.17M derived: sum of 2 quarters · filed 2018-03-12 | $20.16M derived: sum of 3 quarters · filed 2018-03-12 | $23.91M derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $7.21M 10-K · filed 2017-03-16 | $12.20M derived: sum of 2 quarters · filed 2017-03-16 | $15.96M derived: sum of 3 quarters · filed 2017-03-16 | $19.45M 10-K · filed 2018-03-12 |
| 2015-09-30 | $4.99M 10-K · filed 2017-03-16 | $8.74M derived: sum of 2 quarters · filed 2017-03-16 | $12.24M 10-Q · filed 2016-11-09 | $14.02M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $3.75M 10-K · filed 2017-03-16 | $7.25M 10-Q · filed 2016-08-15 | $9.03M derived: sum of 3 quarters · filed 2017-03-16 | $10.38M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $3.49M 10-K · filed 2017-03-16 | $5.27M derived: sum of 2 quarters · filed 2017-03-16 | $6.63M derived: sum of 3 quarters · filed 2017-03-16 | $7.92M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $1.78M 10-K · filed 2016-03-30 | $3.13M derived: sum of 2 quarters · filed 2016-03-30 | $4.43M derived: sum of 3 quarters · filed 2016-03-30 | $5.39M 10-K · filed 2017-03-16 |
| 2014-09-30 | $1.35M 10-K · filed 2016-03-30 | $2.65M derived: sum of 2 quarters · filed 2016-03-30 | $3.61M 10-Q · filed 2015-12-17 | |
| 2014-06-30 | $1.29M 10-K · filed 2016-03-30 | $2.26M derived: sum of 2 quarters · filed 2016-03-30 | ||
| 2014-03-31 | $968.00K 10-K · filed 2016-03-30 | |||
| 2013-12-31 | $3.57M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |